Sunday, 20 March 2022

Reuters Global Healthcare: U.S. FDA approves new Bristol Myers cancer immunotherapy

U.S. FDA approves new Bristol Myers cancer immunotherapy

Bristol Myers Squibb Co said on Friday that U.S. regulators approved the first drug in a new class of cancer immunotherapies as an initial treatment for advanced melanoma, the deadliest form of skin cancer.

Parents up in arms against an Ontario school board's move to keep masks on

The Hamilton-Wentworth District School Board faces a backlash for defying the province's decision to drop masks, setting the stage for a clash.

Hong Kong plans to review COVID restrictions on Monday as cases ease

Hong Kong leader Carrie Lam said on Sunday she plans to review COVID-19 restrictions on Monday, just days after acknowledging that many people in the global financial hub were "losing patience" with the city's coronavirus policies.

China reports first COVID deaths in more than a year

Mainland China reported its first COVID-19 deaths in more than a year on Saturday, according to a post on the National Health Commission's website that said two people died in the northeastern region of Jilin.

Ecuador ends COVID limits on gatherings after hitting vaccination goal

Ecuador's president on Friday announced an end to coronavirus limits on public and private gatherings, but the South American country will continue to require foreign visitors to show proof of vaccinations or a negative COVID-19 test.

CDC reports fewer COVID-19 pediatric deaths after data correction

The U.S. Centers for Disease Control and Prevention reported 966,575 deaths from COVID-19 on Friday after it corrected the data earlier this week, which reduced the death tallies in all age-groups, including children.

Latest on the worldwide spread of the coronavirus

The European Centre for Disease Prevention and Control said countries should provide free COVID-19 testing for refugees from Ukraine to avoid outbreaks as more than three million people flee their war-stricken homeland.

Related Videos

Making heart health a priority for Black women

AstraZeneca shelf life hurts rollout for world's poorest

Easing COVID curbs could cause 2 mln deaths: China study